Sunshine Heart Inc  

(Public, ASX:SHC)   Watch this stock  
Find more results for SHC
0.0000
Delayed:  
ASX data delayed by 20 mins - Disclaimer
Currency in
Range     -
52 week 0.02 - 0.06
Open     -
Vol. 0.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -1.81
Shares     -
Beta     -
Inst. own     -
Mar 5, 2015
Sunshine Heart Inc at Cowen Health Care Conference
  

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -10393.22% -36877.96%
Operating margin -10355.93% -38764.41%
EBITD margin - -38450.85%
Return on average assets -60.61% -61.93%
Return on average equity -65.08% -67.28%
Employees 36 -
CDP Score - -

Address

7651 ANAGRAM DRIVE
EDEN PRAIRIE, MN 55344
United States - Map
+1-952-3454200 (Phone)
+1-302-6365454 (Fax)

Website links

Description

Sunshine Heart, Inc. is an early-stage medical device company focused on developing, manufacturing and commercializing its C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. The C-Pulse Heart Assist System utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. As of December 31, 2013, the Company was in the process of obtaining regulatory approvals necessary to sell its system in the United States. The Company has developed tools to allow the C-Pulse to be implanted through a small pacemaker-like incision between the patient�s ribs and sternum rather than a sternotomy